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San Diego and Torrance, California
O B J E C T I V E S The goal of this study was to assess coronary artery calciﬁcation in patients 10
years or age with a history of Kawasaki disease (KD).
B A C KG ROUND Patients with a history of KD and coronary artery aneurysms are at risk for late
morbidity from coronary artery events. It is unknown whether patients with KD with acutely normal or
transiently dilated coronary arteries also have increased risk of late coronary artery complications.
Coronary calcium scoring using noncontrast computed tomography is a well-established tool for
risk-stratifying patients with atherosclerotic coronary artery disease, but there are limited data on its role
in evaluating patients with a history of KD.
METHOD S We performed coronary artery calcium (CAC) volume scoring using a low radiation dose
computed tomography protocol on 70 patients (median age 20.0 years) with a remote history of KD
(median interval from acute KD to imaging 14.8 years). Forty-four (63%) patients had no history of
coronary dilation, 12 (17%) had a history of transient dilation, and 14 (20%) had coronary aneurysms.
R E S U L T S All of the patients with normal coronary artery internal diameter during the acute phase
of KD and 11 of 12 patients with transient dilation had CAC scores of zero. Coronary calciﬁcation was
observed in 10 of the 14 patients with coronary aneurysms, with the degree of calciﬁcation ranging from
mild to severe and occurring years after the patients’ acute KD.
CONC L U S I O N S Coronary calciﬁcation was not observed in patients with a history of KD and
normal coronary arteries during the acute phase. Therefore, CAC scanning may be a useful tool to screen
patients with a remote history of KD or suspected KD and unknown coronary artery status. Coronary
calciﬁcation, which may be severe, occurs late in patients with coronary aneurysms. The pathophysiol-
ogy and clinical implications of coronary calciﬁcation in patients with aneurysms are currently unknown
and warrant further study. (J Am Coll Cardiol Img 2012;5:264–72) © 2012 by the American College of
Cardiology Foundation
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265awasaki disease (KD), the most common cause
of acquired heart disease in children, is an acute
vasculitis associated with the formation of
coronary aneurysms in 25% of untreated cases
nd 5% of patients treated with intravenous immuno-
lobulin (1–3). Patients with a history of KD and
neurysm formation are at risk for coronary artery
hrombosis, stenosis, myocardial infarction, and death
2,4–7). Patients with aneurysms are known to de-
osit calcium in the arterial wall in sites of antecedent
nflammation, and such dramatic calcifications can be
oted on chest radiographs decades after the acute
isease (8). Those with a history of KD without
neurysm formation have a benign course in the short
erm, but whether they are at increased risk for
oronary and myocardial complications later in life is
urrently unknown (9). As a result, there is a need for
etter tools to identify patients at increased risk and to
elp risk-stratify patients for appropriate medical
reatments such as antiplatelet, anticoagulation, and
ipid-lowering therapies and invasive treatments such
s percutaneous coronary intervention and coronary
rtery bypass surgery (CABG) (5,6).
Coronary artery calcium (CAC) scoring using com-
uted tomography (CT) has a proven role in detecting
nd managing atherosclerotic coronary artery disease
CAD) and is highly predictive of mortality (10–12).
his examination uses a relatively low radiation dose,
equires no contrast, is inexpensive, and provides a
ingle score that can be useful in patient management
10,13). For atherosclerotic CAD, the CT CAC score
isk-stratifies patients more accurately than traditional
isk factors (11).
Thus far, the role of CAC scoring in the manage-
ent of patients with a history of KD has not been
ystematically studied. In 1 study of 18 patients (mean
ge 12.8 years) with a history of KD investigated using
lectron-beam CT, elevated CAC scores were only
bserved in those patients with coronary aneurysms,
nd the patient with the highest CAC score suffered
udden cardiac death (14). In another study of 79
atients with KD and a history of abnormal coronary
rteries acutely, electron-beam CT was used to assess
he presence of qualitative calcification (15). We
eport here the results of CAC scoring using
ultislice CT in a diverse population of patients
ith a distant history of KD both with and
ithout coronary aneurysms.
M E T H O D S
Study population. A total of 70 patients were en-
olled from 2 separate cohorts. We enrolled 44atients (age 10 years) recruited from those orig-
nally diagnosed, treated, and followed up by the
awasaki Disease Research Center at the Univer-
ity of California, San Diego Medical Center and
ady Children’s Hospital (cohort 1). In addition,
e enrolled 26 patients who were self-referred for
ur study or responded to recruiting efforts (cohort
), the majority of whom became aware of the study
ia word-of-mouth and locally held informational
ymposia. For cohort 2, a total of 23 of the patients
ad a known history of KD. In the remaining 3
atients, the diagnosis of KD was based on the
resence of proximal coronary artery aneurysms diag-
osed using CT or coronary angiography indepen-
ently reviewed by 2 cardiologists and a history of a
D-compatible illness obtained through interview of
he patient or his or her parents. This study was
pproved by the institutional review board of the
niversity of California, and all patients or their
arents provided written informed consent.
The coronary artery status at the time of
he patient’s acute KD presentation was
etermined from the initial evaluation using
chocardiography and by repeat imaging
ith echocardiography, invasive coronary
ngiography, or computed tomography an-
iography (CTA) where available. For those
atients with coronary artery abnormalities,
ubsequent coronary artery status was deter-
ined by the most recent clinically indicated
TA or invasive coronary angiography re-
ults. Data from 1 of these 2 tests were
vailable for all of the patients with coronary
neurysms. Patients were grouped into 4 cat-
gories: 1) no history of coronary artery dila-
ion (American Heart Association risk level I) (9);
) transient coronary artery dilation that subsequently
esolved (American Heart Association risk level 2);
) persistent coronary artery aneurysms 8 mm in
iameter; or 4) persistent giant coronary aneurysms
8 mm in diameter. Major adverse cardiac events
MACE) were defined as a history of CABG, myo-
ardial infarction, or percutaneous coronary interven-
ion.
Risk factors for CAD. All patients completed a stan-
dardized questionnaire that documented current
medications and assessed risk factors for atheroscle-
rotic CAD: physician-diagnosed hypertension, di-
abetes mellitus, hyperlipidemia, family history of
early atherosclerotic CAD (defined as disease diag-
nosed at55 years-of-age in a first-degree relative),
and current smoking. Height and weight were
A B B
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266mass index (BMI [in kilograms per meters
squared]) was computed.
CT scanning protocol. Patients were scanned during
single breath-hold using a 64-slice Discovery
T750 HD scanner (GE Healthcare, Milwaukee,
isconsin) with a customized protocol designed to
inimize the administered radiation dose. All but 3
f the patients were scanned using a tube energy of
00 kVp (instead of the tube energy of 120 kVp
raditionally used for calcium scoring) in gated axial
ode. The tube current was adjusted on the basis of
he BMI to give adequate signal-to-noise ratio
hile minimizing the net current, using the empir-
cally determined formula: tube current (mA)  11
BMI. The time of imaging during the cardiac
cycle was adjusted on the basis of heart rate,
imaging at 75% of the R-R interval for heart
rate 75 beats/min, and at 50% of the R-R
interval for heart rate 75 beats/min. The slice
thickness was 2.5 mm, the gantry rotational period
was 0.35 s, and the scan length was adjusted from
the scout images to encompass the entire heart. The
median radiation dose–length product was 42
mGy·cm, which, using a conversion factor of 0.014
mSv/mGy·cm, corresponds to a median effective
radiation dose of 0.59 mSv (16). The minimum, first
quartile, third quartile, and maximum doses were
0.32, 0.49, 0.68, and 1.46 mSv, respectively (of note,
the maximum dose was for 1 of the 3 patients scanned
using 120 kVp). The minimum, first quartile, median,
third quartile, and maximum effective radiation doses
divided by body mass were 0.0064, 0.0086, 0.0095,
0.011, and 0.020 mSv/kg, respectively.
CTA was performed in selected patients when
clinically indicated using the scanner described
earlier. Oral and/or intravenous metoprolol was
administered as needed to decrease the patients’
heart rate, with a goal heart rate of 60 beats/min.
A timing bolus with 10 ml of iodinated contrast and
subsequent sequential imaging and analysis of a single
slice at the level of the left main coronary artery were
used to determine the optimal imaging time. Iodin-
ated contrast was injected with a triple-phase tech-
nique (contrast, contrast/saline mix, and saline) with
the dose, mixture, and flow rate adjusted for the
patients’ BMI. The tube voltage and current were also
adjusted for the patients’ BMI. Images were obtained
during a single breath-hold using prospective gating
with imaging centered at 75% of the R-R interval and
a slice thickness of 0.625 mm.
Image analysis. Images for CAC scoring were re-
onstructed using a 512  512 matrix and analyzed
ffline using a Ziostation workstation (Ziosoft, Inc.,edwood City, California). For each patient, the
otal coronary calcium volume was calculated using
minimum threshold of 147 HU, following the
ork of Nakazato et al. (17), to adjust for the lower
ube energy, and a minimum volume of 2.5 mm3.
For the 3 patients scanned using 120 kVp, the
traditional 130-HU threshold was used (18). Re-
gions of calcification of the coronary arteries were
manually identified on the workstation, and the
total volume of coronary calcification was calculated
for each patient. Regions of coronary arteries with
stents were excluded from scoring due to artifacts
from the stents. CTA images were viewed, recon-
structed, and analyzed using a Vitrea workstation
(Vital Images, Inc., Minnetonka, Minnesota).
Statistical analysis. For each group of patients, medi-
ns and quartiles were calculated for all continu-
us parameters studied. Spearman rank order
orrelation was used to assess the correlation
etween continuous variables. For all tests, a 2-sided
value 0.05 was considered statistically significant.
R E S U L T S
Demographic characteristics. Patients ranged in age
from 10.3 to 59.8 years with a median age of 20.0
years. The median interval from the onset of KD to
the time of imaging was 14.8 years. Of the 70 patients,
44 (63%) had no history of coronary dilation, 12
(17%) had a history of transient dilation, and 14 (20%)
had aneurysms. Six patients (9%) had giant (8 mm
in diameter) aneurysms (Table 1).
Diabetes mellitus, hypertension, and current
smoking were each present in10% of the patients.
A history of hyperlipidemia was present in 16% of
the patients, and 36% had a family history of early
CAD. The majority (38 patients [54%]) had no risk
factors for CAD, 23 (33%) had 1 risk factor, and 9
(13%) had 2 risk factors. Of the 38 patients with
1 coronary risk factor, 25 (66%) had a family history
of early CAD. Five patients were receiving statin
medications, and 2 patients were receiving niacin.
Six of the patients were receiving systemic antico-
agulation: 5 patients were on warfarin and 1 patient
was on dabigatran.
CAC volume scores. Table 2 displays the CAC
cores as a function of coronary artery status. No
alcification was detected in any of the patients
hose coronary artery internal diameter was al-
ays assessed as normal. Of the patients with
ransient coronary dilation, only 1 patient had
alcification. For patients with aneurysms 8mm in diameter and for those with giant aneu-
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267rysms, a wide range of calcium scores was ob-
served (see examples shown in Figs. 1B, 2, and 3);
scores ranged from zero to 8,000 mm3, indic-
ative of severe calcification.
Overall, 59 (84%) of the patients studied had
no coronary calcification, and 11 (16%) had
calcification. The majority of the patients with
calcification (8 of 11) had 1 cardiac risk factor:
4 had none and 4 had only 1 risk factor. Of these
11 patients with calcification, 9 had a history of
MACE (6 had undergone CABG, 2 had myo-
cardial infarctions, and 1 had undergone percuta-
Table 1. Patient Characteristics
Men
Age at onset of KD (yrs): ﬁrst quartile, median, third quartile
Age at time of CT (yrs): ﬁrst quartile, median, third quartile
Interval from onset of KD to CT scan (yrs): ﬁrst quartile,
median, third quartile
Coronary artery status
No dilation
Transiently dilated
Aneurysm 8 mm in diameter
Giant aneurysm (8 mm in diameter)
Cardiovascular risk factors
Hypertension
Diabetes mellitus
Current smoking
Hyperlipidemia
Family history of early CAD (55 yrs)
Body mass index (kg/m2): ﬁrst quartile, median, third quartile
Medications
Statin medication
Niacin
ACE-I or ARB
Beta-blocker
Calcium channel blocker
Warfarin or dabigatran
Aspirin
Clopidogrel
Values are n (%). Cohort 1 indicates patients originally diagnosed, treated, and f
San Diego Medical Center and Rady Children’s Hospital; cohort 2 indicates all
ACE-I  angiotensin-converting enzyme inhibitor; ARB  angiotensin II rece
Kawasaki disease.
Table 2. Calcium Score Results
Coronary Artery Status 0
No dilation 44
Transiently dilated 11
Aneurysm 8 mm in diameter 3Giant aneurysm (8 mm in diameter) 1neous coronary intervention with stent placement).
Of the 14 patients with coronary aneurysms, 9 had
MACE, all but 1 of whom had a positive CAC
score. The 1 patient with a MACE and a CAC
score of zero was a 19-year-old man with giant
coronary aneurysms who suffered a myocardial in-
farction 6 years after KD onset while not taking
anticoagulation medication. Of the 5 patients tak-
ing warfarin, all had aneurysms and 4 of them had
positive CAC scores. The 1 patient taking warfarin
without calcification was studied 6 years after his
episode of acute KD.
Cohort 1
(n  44)
Cohort 2
(n  26)
Total
(N  70)
27 (61) 15 (58) 42 (60)
1.2, 2.4, 5.9 3.0, 4.5, 7.5 1.4, 3.4, 6.5
13.4, 16.7, 20.5 21.6, 27.7, 32.4 14.7, 20.0, 24.8
10.5, 13.4, 16.0 13.0, 24.5, 28.3 10.9, 14.8, 23.8
26 (59) 18 (69) 44 (63)
11 (25) 1 (4) 12 (17)
5 (11) 3 (12) 8 (11)
2 (5) 4 (15) 6 (9)
2 (5) 2 (8) 4 (6)
1 (2) 1 (4) 2 (3)
3 (7) 2 (8) 5 (7)
5 (11) 6 (23) 11 (16)
14 (32) 11 (42) 25 (36)
19, 21, 24 20, 22, 24 19, 22, 24
2 (5) 3 (12) 5 (7)
1 (2) 1 (4) 2 (3)
3 (7) 3 (12) 6 (9)
3 (7) 3 (12) 6 (9)
2 (5) 0 (0) 2 (3)
3 (7) 3 (12) 6 (9)
5 (11) 10 (38) 15 (21)
2 (5) 2 (8) 4 (6)
ed up by the Kawasaki Disease Research Center at the University of California,
patients.
blocker; CAD  coronary artery disease; CT  computed tomography; KD 
Calcium Volume (mm3)
1–100 101–1,000 >1,000
0 0 0
0 1 0
3 0 2ollow
other
ptor0 2 3
mp
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268The CAC scan from the 1 patient with transient
coronary dilation during his acute KD and a positive
CAC score is shown in Figure 1A. This 33-year-old
man with no cardiac risk factors and a history of KD
at 5 years of age presented with unstable angina.
Results of invasive angiography demonstrated a 90%
Figure 1. CT CAC Scans
(A) A 33-year-old man with a history of Kawasaki disease (KD) at 4
coronary calciﬁcation of the left anterior descending artery (arrows
giant coronary aneurysms, and a coronary artery calcium (CAC) sca
(arrowhead) and left anterior descending arteries (arrows). CT  co
Figure 2. Serial CT Angiograms Showing Progressively Increasin
In a patient with a history of KD at 3 years of age, serial CT angiog
onset. Studies show progressively increasing calciﬁcation of the right coleft main coronary artery stenosis, which was treated
with urgent CABG.
An analysis of the CAC scores as a function of
the time since the patients’ episodes of acute KD
revealed that all patients with positive CAC scores
had their acute KD at least 10 years before their
s of age, a history of transient coronary dilation, and signiﬁcant
d (B) a 44-year-old woman with a history of KD at 13 years of age,
monstrating severe coronary calciﬁcation of the right coronary
uted tomography.
alciﬁcation
s performed at (A) 7 years, (B) 8 years, and (C) 10 years after KDyear
) an
n deg C
ram
ronary artery (arrows). Abbreviations as in Figure 1.
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269scan (Fig. 4). However, the degree of calcification
did not correlate with the time since acute KD (rs
0.05, p  0.88).
D I S C U S S I O N
Patients with no acute coronary abnormalities. Every
patient who had normal-appearing coronary arteries
in the acute KD phase had no coronary calcifica-
tion, consistent with the previous findings of
Dadlani et al. (14). Subclinical pathology in such
patients has been assessed by measuring coronary
flow reserve, which yielded mixed results, with
some studies showing impaired coronary flow re-
serve (19,20) and others showing no difference from
controls (21,22). The absence of calcification in our
patients does not exclude the possibility of impaired
endothelial function as well as structural damage to
Figure 3. CT Images from a Patient With Giant Aneurysms and Co
CT angiogram and calcium scan on a Vietnamese man from cohort
ness at 6 years of age. The patient presented at 22 years of age wi
right coronary artery. CT angiography performed 4 years later show
seen in (A) 3-dimensional reconstruction, (B, arrows) oblique cross
artery with occlusive thrombus. (D) An image from the patient’s ca
descending artery (arrow). Abbreviations as in Figure 1.the arterial wall and hence some subclinical pathol-ogy. Autopsy studies have raised concerns that
abnormal remodeling of the arterial wall can occur
in the absence of documented changes during the
acute illness (23,24). Long-term, longitudinal stud-
ies of patients with normal echocardiograms during
the acute illness are needed to address this question.
Patients with transient coronary dilation. In this
study, the number of patients with transient coro-
nary artery dilation was relatively small. Only 1 of
these patients had coronary calcification. However,
this condition was associated with a significant
clinical outcome requiring urgent CABG. Al-
though it is conceivable that this patient’s CAD was
not due to his KD, this was a relatively young man
with no risk factors for atherosclerotic CAD, and
hence this possibility seems unlikely. Had he un-
dergone calcium scoring, this patient could have
been identified as a high-risk patient and had
ary Artery Thrombosis
ith no cardiac risk factors and a history of a KD–compatible ill-
n acute myocardial infarction and thrombotic occlusion of the
large sequential aneurysms of the left anterior descending artery
ion, and (C) a 28-mm aneurysm (arrows) of the right coronary
scan demonstrating signiﬁcant calciﬁcation of the left anteriorron
2 w
th a
ed
sect
lciumearlier, elective intervention. In the previous study
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270by Dadlani et al. (14), in which the patients were
younger and imaged sooner (mean age 12.8 years;
mean elapsed time since acute KD 8.6 years), there
were only 4 patients with transient dilation, and none
had coronary calcification. Given the relatively small
number of patients studied, and the presence of
significant calcification in 1 patient, this is a category
that merits further study and for which the utility and
implications of CT CAC scoring remain unclear.
Patients with aneurysms. From our data and consis-
tent with previous work (8,14,15), it seems clear
that patients with aneurysms have a high likelihood
of developing calcification of their coronary arteries.
Our data suggest that it may take approximately 10
years for significant calcification to develop. By
comparison, in the study by Kaichi et al. (15), for
coronary arteries with initial diameters 6 mm, the
prevalence of coronary calcification was 12% at 5
years, 44% at 10 years, and 94% at 20 years. Once
calcification does develop, in our data, the CAC
volumes did not correlate with the elapsed times
since the initial episodes of KD.
Radiation dose from CAC scoring. Although the ef-
fects of radiation at small doses are unknown with
certainty, minimizing the radiation dose is desirable
and considered good medical practice. Radiation
doses are of particular concern in younger patients,
in whom there may be greater risk from radiation
(25). We used a customized protocol specifically
designed to minimize the radiation administered
while still providing diagnostic data. The median
radiation dose of 0.59 mSv used in this study is
much lower than that previously reported for CAC
Figure 4. CAC Volume Scores Versus Time Since Acute KD
CT calcium volume scores (on a logarithmic scale), presented as a f
to coronary artery status. The vertical dotted line indicates 10 yearscoring using multidetector CT (13). By compari-son, the average annual radiation dose from natural
sources in the United States is approximately 3 mSv
(26). Hence, on average, this examination is equiv-
alent to just 2.4 months of natural radiation expo-
sure and imparts a lower dose than invasive angiog-
raphy, CTA, and cardiac nuclear stress testing (26).
Mechanism of calciﬁcation. The underlying mecha-
nisms causing coronary arteries to calcify in KD
patients are currently unclear; possibilities include
inflammatory, immunologic, treatment-related, or he-
modynamic factors or some combination of these.
Calcification may be the long-term result of damage
from the initial inflammatory insult associated with
coronary aneurysm formation. Alternatively, recent
patient-specific modeling of hemodynamics in a pa-
tient with giant aneurysms demonstrated that the
presence of aneurysms resulted in abnormal flow
patterns with markedly increased flow recirculation
times and reduced wall shear stress within the aneu-
rysms (27). Correlating regions of hemodynamic ab-
normalities with those that develop increased calcifi-
cation may help clarify the possible connection.
Recently, Zhu et al. (28) found that vascular calcifi-
cation is associated with up-regulation of alkaline
phosphatase and the sodium-dependent phosphate
transporter PiT-1, which are known osteocytic mole-
cules. What role genetics may play and whether
up-regulation of these proteins is occurring in some
patients with KD is currently unknown. Vascular
calcification has also been associated with warfarin use
(29). In our study, only 5 patients were receiving
warfarin. Although 4 of these 5 had positive CAC
scores, these were also patients with aneurysms for
ion of the time since the patients’ acute KD and coded according
er onset of KD. Abbreviations as in Figure 1.unct
s aftwhom 10 years had elapsed since their episode of
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271acute KD. Hence, due to the small number of patients
receiving warfarin and the presence of confounding
factors, no clear conclusions regarding the effects of
warfarin use can be drawn from our study data.
Clinical implications. The use of CT calcium scoring
ith a low-radiation protocol may contribute to the
anagement of patients with a history of KD and
nknown coronary artery status. In such patients,
he finding of coronary calcification suggests signif-
cant coronary pathology and should prompt further
linical evaluation, typically with CTA to evaluate
or the presence of coronary aneurysms and stenoses.
For patients with aneurysms who develop severe
alcification, the clinical implications are currently
nclear. In the case of atherosclerotic heart disease,
igh calcium scores identify patients at increased
isk of cardiovascular events and mortality, probably
ecause these patients have more extensive vascular
athology (12). However, for a given coronary
esion, CT data have shown that the lack of
alcification or the presence of spotty calcification
re associated with increased events, possibly be-
ause these plaques have higher lipid content and
ence are more prone to rupture (30–33).
The coronary lesions in KD have a different patho-
hysiology than coronary atherosclerosis, and their
atural history into adulthood is largely unknown
34). Postmortem case report literature has docu-
ented that extensive arterial wall dystrophic calcifi-
ation occurs in coronary artery aneurysms late after
D (35). A frequent cause of coronary events in
atients with KD is thrombus formation within an-
urysms and subsequent coronary occlusion. In addi-
ion, patients may experience stenoses at the distal
ortions of the aneurysms. Future longitudinal clinical
tudy will be required to determine whether the degree
f calcification in patients with a history of KD is a
isk factor for events or is protective. Hence, using CT
AC scoring to assess the degree of calcification may
e useful in risk-stratifying patients with KD andet al. A single intravenous infusion of 118:2763–72.alcification to develop, our data suggest that the
otential utility of such scanning would probably be
estricted to patients for whom approximately 10
ears have elapsed since having acute KD.
Study strengths and limitations. Strengths of this
study include our study population, which included
patients with a range of KD pathology, ages, and
elapsed time since their acute KD occurred. Also, the
CT protocol used a very low radiation dose while still
providing diagnostic data in all patients. This study
also has several limitations. The patients in cohort 2
were self-referred to this study or responded to re-
cruiting efforts and hence may not be representative of
KD patients overall. In addition, 1 of the patients had
stents in his coronary arteries. Because these regions
are likely to be among the most diseased segments and
were necessarily excluded from calcium scoring, this
fact likely resulted in an underestimation of the cal-
cium scores for this patient. Finally, the relatively
small sample size, particularly for the transiently di-
lated patients, limits our ability to draw conclusions or
make recommendations about the use of CAC scor-
ing in this group of patients.
C O N C L U S I O N S
We used low-dose noncontrast CT scanning to
assess coronary calcification in patients with a re-
mote history of KD. Our primary findings were that
patients with no coronary artery dilation had no
calcification and that those with aneurysms devel-
oped significant calcification approximately 10 years
after their episode of acute KD. The pathophysiol-
ogy and clinical implications of coronary calcifica-
tion in this population will require further study.
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